Patent applications and USPTO patent grants for Mission Pharmacal Company.The latest application filed is for "novel formulations for the treatment of vaginal disorders".
Patent | Date |
---|---|
Sprayable composition containing zinc oxide and a fluoro-olefin propellant Grant 11,007,151 - Dann , et al. May 18, 2 | 2021-05-18 |
Spray delivery device Grant 10,239,685 - Dann , et al. | 2019-03-26 |
Stabilized, sprayable emulsion containing active agent particles Grant 9,700,510 - Dann , et al. July 11, 2 | 2017-07-11 |
Novel Formulations For The Treatment Of Vaginal Disorders App 20170182006 - BERGERON; Michel G. ;   et al. | 2017-06-29 |
Stabilized, Sprayable Emulsion Containing Active Agent Particles App 20160279061 - Dann; Thomas ;   et al. | 2016-09-29 |
Formulations for the treatment of vaginal disorders Grant 9,446,024 - Bergeron , et al. September 20, 2 | 2016-09-20 |
Stabilized, sprayable emulsion containing active agent particles Grant 9,381,156 - Dann , et al. July 5, 2 | 2016-07-05 |
Sprayable Composition Containing Zinc Oxide and a Fluoro-Olefin Propellant App 20150231071 - Dann; Thomas ;   et al. | 2015-08-20 |
Stabilized, Sprayable Emulsion Containing Active Agent Particles App 20150231072 - Dann; Thomas ;   et al. | 2015-08-20 |
Spray Delivery Device App 20150232260 - Dann; Thomas ;   et al. | 2015-08-20 |
Novel Formulations For The Treatment Of Vaginal Disorders App 20150080443 - BERGERON; Michel G. ;   et al. | 2015-03-19 |
Dual cation dual anion coordination complexes Grant 8,859,824 - Walter , et al. October 14, 2 | 2014-10-14 |
Methods and compositions to inhibit edema factor and adenylyl cyclase Grant 8,003,692 - Schein , et al. August 23, 2 | 2011-08-23 |
Calcium-enriched food product Grant 7,968,130 - Walter , et al. June 28, 2 | 2011-06-28 |
Calcium-enriched food product Grant 7,968,131 - Walter , et al. June 28, 2 | 2011-06-28 |
Powder Mix Of Potassium Calcium Citrate For The Treatment Of Kidney Stones And Osteoporosis App 20100227006 - Pak; Charles Y. C. ;   et al. | 2010-09-09 |
Dual Cation Dual Anion Coordination Complexes App 20100184866 - Walter; Mary Ann ;   et al. | 2010-07-22 |
Methods and Compositions to Inhibit Edema Factor and Adenylyl Cyclase App 20090093519 - Schein; Catherine H. ;   et al. | 2009-04-09 |
Short Term Slow Release Drug Delivery System App 20080131504 - Walsdorf, Sr.; Neill B. ;   et al. | 2008-06-05 |
Calcium-Enriched Food Product App 20070160714 - Walter; Mary A. ;   et al. | 2007-07-12 |
Dietary supplementation with stoichiometrically specific potassium magnesium citrate Grant 7,091,246 - Rushforth August 15, 2 | 2006-08-15 |
Calcium glutarate supplement and phosphorus binder Grant 6,887,897 - Walsdorf, Sr. , et al. May 3, 2 | 2005-05-03 |
Dietary supplements containing ultradense calcium citrate and carbonyl iron Grant 6,818,228 - Walsdorf , et al. November 16, 2 | 2004-11-16 |
Potassium calcium citrate compositions and methods therefor Grant 6,287,607 - Pak , et al. September 11, 2 | 2001-09-11 |
Manual pump with inherent vacuum limit Grant 5,782,621 - Harris July 21, 1 | 1998-07-21 |
Calcium supplementation by dicalcium citrate-lactate Grant 5,075,499 - Walsdorf , et al. December 24, 1 | 1991-12-24 |
Slow-release sodium fluoride tablet and method for treatment of osteoporosis Grant 4,904,478 - Walsdorf , et al. February 27, 1 | 1990-02-27 |
Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid Grant 4,851,221 - Pak , et al. July 25, 1 | 1989-07-25 |
NCAGE Code | 09FB2 | MISSION PHARMACAL COMPANY |
NCAGE Code | 1RFQ2 | MISSION PHARMACAL COMPANY |
NCAGE Code | 23752 | MISSION PHARMACAL COMPANY |
CAGE Code | 09FB2 | MISSION PHARMACAL COMPANY |
CAGE Code | 1RFQ2 | MISSION PHARMACAL COMPANY |
CAGE Code | 23752 | MISSION PHARMACAL COMPANY |
S.A.M. Registration | 09FB2 [8117095] | MISSION PHARMACAL COMPANY |
DUNS | 927726893 | MISSION PHARMACAL COMPANY |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.